DBI and brain neoplasm: ACSS2 [17], FASN [123], ELOVL2 [27] and acyl-CoA binding-protein (ACBP) [28] are examples of the key pathway enzymes for acetyl-CoA and fatty acid synthesis, which have been identified as potential drug targets for RTK- or EGFR-driven brain tumors.